Catalyst Wire Dossier Catalyst Wire Dossier

CNGA3 gene therapy

CNGA3 gene therapy · MeiraGTx UK II Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CNGA3 gene therapy, covering 2022-02-11 to 2022-02-11. Get the full timeline:

Most recent: Clinical Trial Update: Gene Therapy for Achromatopsia (CNGA3) [Phase 1, Phase 2]

See pricing